Détail de l'auteur
Documents disponibles écrits par cet auteur (30)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Galli F ; Bragg L ; Rossi M ; Proietti D ; Perani L ; Bagicaluppi M ; Tonlorenzi R ; Sibanda T ; Caffarini M ; Talapatra A ; Santoleri S ; Meregalli M ; Bano-Otalora B ; Bigot A ; Bozzoni I ; Bonini C ; Mouly V ; Torrente Y ; Cossu G | 04/03/2024Correction to: EMBO Molecular Medicine (2024) 16:927–944. https://doi.org/10.1038/s44321-024-00031-3 | Published online 4 March 2024 An author’s name is corrected Author affiliation number 2 is corrected The author name Marco Bagicaluppi [...]
Article
Ruparelia AA ; McKaige EA ; Williams C ; Schulze KE ; Fuchs M ; Oorschot V ; Lacene E ; Meregalli M ; Lee C ; Serrano RJ ; Baxter EC ; Monro K ; Torrente Y ; Ramm G ; Stojkovic T ; Lavoie JN ; Bryson-Richardson RJ | United States | 2020
Article
Sitzia C, Auteur ; Meregalli M ; Belicchi M ; Farini A ; Arosio M ; Bestetti D ; Villa C ; Valenti L ; Brambilla P ; Torrente Y | Switzerland | 07/2019
Article
Frattini P, Auteur ; Villa C ; de Santis F ; Meregalli M ; Belicchi M ; Erratico S ; Bella P ; Raimondi MT ; Lu Q ; Torrente Y | 2017
Article
Sitzia C, Auteur ; Farini A ; Jardim L ; Razini P ; Belicchi M ; Cassinelli L ; Villa C ; Erratico S ; Parolini D ; Bella P ; da Silva Bizario JC ; Garcia L ; Dias-Baruffi M ; Meregalli M ; Torrente Y | 2016
Article
Meregalli M, Auteur ; Farini A ; Sitzia C ; Beley C ; Razini P ; Cassinelli L ; Colleoni F ; Frattini P ; Santo N ; Galbiati E ; Prosperi D ; Tavelli A ; Belicchi M ; Garcia L ; Torrente Y | 2015
Article
Meregalli M ; Farini A ; Sitzia C ; Torrente Y | 2014
Article
Meregalli M ; Navarro C ; Sitzia C ; Farini A ; Montani E ; Wein N ; Razini P ; Beley C ; Cassinelli L ; Parolini D ; Belicchi M ; Parazzoli D ; Garcia L ; Torrente Y | 2013
Article
Meregalli M ; Farini A ; Colleoni F ; Cassinelli L ; Torrente Y | 2012Accès au résumé Pubmed/to pubmed abstract
Article
Farini A ; Navarro C ; D'Antona G ; Belicchi M ; Parolini D ; Bottinelli R ; Meregalli M ; Torrente Y | AFM-TELETHON | 2011Limb Girdle Muscular Dystrophies (LGMDs) are a group of muscular diseases characterized by predominant weakness and wasting of muscles of the pelvic and shoulder girdle. LGMD-2B and MM were found to arise from defects in the dysferlin gene. In L[...]
Article
Belicchi M ; Razini P ; Farini A ; Meregalli M ; Villa C ; Bresolin N ; Torrente Y | 2011Adult stem cells reside in all tissues, where they maintain homeostatic conditions and respond to injuries. These cells are regulated and supported by the surrounding microenvironment, called stem cell "niche", composed by cellular and molecular[...]
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Villa C ; Farini A ; Erratico S ; Belicchi M ; Meregalli M ; Fiori F ; Rustichelli F ; Torrente Y | 2011Cell therapy is an emerging approach of regenerative medicine with significant efforts in clinical areas. Stem cells cannot be easily observed directly when injected systemically, and, therefore, their behaviors need to be visualized indirectly.[...]
Article
Erratico S ; Villa C ; Razini P ; Cassinelli LM ; Parolini D ; Meregalli M ; Belicchi M ; Torrente Y | AFM-TELETHON | 2011Peripheral blood is a promising alternative source of stem cells for transplantation for the treatment of different malignancies. Using CD133, as a marker of stemness, we identified a subpopulation of purified blood-derived stem cells which diff[...]
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Del Fraro G ; Meregalli M ; Farini A ; Belicchi M ; Parolini D ; Razini P ; Cassinelli L ; Angeloni V ; Maciotta S ; Bresolin N ; de Silva Bizario J ; Garcia L ; Torrente Y | 2011In DMD, skeletal and cardiac muscles are affected, leading to wheelchair dependency, respiratory failure and premature death. A combination of different strategies might enhance the possibility of successful therapy. We isolated CD133+ cells fro[...]
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Cassinelli LM ; Maciotta S ; Gandolfi F ; Forcato M ; Bicciato S ; Meregalli M ; Torrente Y | 2011Duchenne muscular dystrophy (DMD) is a common X-linked disease characterized by frameshift mutations in the dystrophin gene. Among the molecular mechanisms potentially involved in DMD, we focused our attention on microRNAs (miRNAs) a new class o[...]
Article
Meregalli M ; Farini A ; Parolini D ; Maciotta S ; Torrente Y | 2010Accès au résumé PubMed / to PubMed abstract
Article
Diaz-Manera J ; Touvier T ; Dellavalle A ; Tonlorenzi R ; Tedesco FS ; Messina G ; Meregalli M ; Navarro C ; Perani L ; Bonfanti C ; Illa I ; Torrente Y | 2010Accès au résumé PubMed / to PubMed abstract 08/09/2011 - La transplantation de mésoangioblastes murins restaure partiellement l’expression de dysferline dans un modèle murin de dysferlinopathie La dysferline est une protéine du mu[...]
Article
Marchesi C ; Belicchi M ; Meregalli M ; Farini A ; Cattaneo A ; Parolini D ; Gavina M ; Porretti L ; D'Angelo MG ; Bresolin N ; Torrente Y | 05/2008
Article
Belicchi M ; Meregalli M ; Marchesi C ; Lopa R ; Porretti L ; Parolini D ; D'Angelo MG ; Bresolin N ; Torrente Y | 2008Although the natural history of patients with Duchenne Muscular dystrophy (DMD) is characterized by a progressive impairment of muscle function leading to death for cardio-pulmonary failure, there is a clinical variability in these patients rega[...]
Article
Meregalli M ; Farini A ; D'Antona G ; Belicchi M ; Goyenvalle A ; Parolini D ; Bresolin N ; Bottinelli R ; Garcia L ; Torrente Y | 2008Several recent advances have pointed out a variety of possible therapeutic approaches in muscular dystrophies, from pharmacological treatments to gene therapy and cell therapy with different types of newly identified stem cells. A combination of[...]
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Belicchi M ; Meregalli M ; Razini P ; Cattaneo A ; Farini A ; Iacchetti E ; Porretti L ; Milani P ; Bresolin N ; Torrente Y | 2008The use of stem cells in regenerative medicine and cell-based therapies offers immense potential in diseases witch have currently no treatment such as Duchenne muscular dystrophy. A limitation to the use of CD133+ for a therapeutic application i[...]
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Navarro C ; Farini A ; Meregalli M ; Belicchi M ; Parolini D ; Razini P ; Krahn M ; Wein N ; Bourg N ; Bartoli M ; Richard I ; Torrente Y | 2008Mutations in gene encoding Dysferlin are involved in Limb-gird Muscular Dystrophy type 2B (LGMD-2B) and and Miyoshi myopathy (MM), both diseases are characterized by progressive weakness and wasting of skeletal muscles. Dysferlin is abundantly e[...]
Article
Meregalli M ; Farini A ; Torrente Y | 2008Accès au résumé PubMed / to PubMed abstract
Article
Benchaouir R ; Meregalli M ; Farini A ; D'Antona G ; Belicchi M ; Goyenvalle A ; Battistelli M ; Bresolin N ; Bottinelli R ; Garcia L ; Torrente Y | 01/2008Accès au résumé PubMed / to PubMed abstract
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Maciotta S ; Meregalli M ; Farini A ; Belicchi M ; Parolini D ; Bresolin N ; Torrente Y | 2008DMD is caused by frameshift mutations in the gene encoding for dystrophin. These mutations are responsible for the loss of function of the dystrophin protein that leads to membrane destabilization and subsequent activation of pathophysiological [...]
